Rafael Holdings RFL
NYSE RFL
$1.28 +0.00 (+0.00%)
As of: Oct 23, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Rafael Holdings (RFL) posted Return on Capital Employed [ROCE] of -43.04% for fiscal Q3 2026 (quarter ended Apr 30, 2026), down 19.10 percentage points from -23.94% a year earlier and down 3.63 percentage points from the prior quarter.

Analysis

Rafael Holdings (RFL) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025 (ended Jul 31, 2025), Rafael Holdings' Return on Capital Employed [ROCE] came in at -31.06%, up 82.57 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -24.72 percentage points (FY2020 to FY2025).
  • In prior fiscal years, Rafael Holdings' Return on Capital Employed [ROCE] was -113.63% in FY2024 (-99.50 pp), -14.13% in FY2023 (+38.38 pp), -52.51% in FY2022 (-30.47 pp) and -22.05% in FY2021 (-15.71 pp).
  • The fiscal Q3 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q2 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of -0.33 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was fiscal Q2 2026, with a gain of 97.81 percentage points; the weakest was fiscal Q2 2025, with a drop of 125.68 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior fiscal quarters was -39.42% (Q2 2026), -36.30% (Q1 2026) and -29.30% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.52%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 17.92%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.28%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 16.76%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.86%
10 Rafael Holdings 67.11 Mn -99.50 Mn 163,000.00 -43.04%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -43.04%
Jan 31, 2026 -39.42%
Oct 31, 2025 -36.30%
Jul 31, 2025 -29.30%
Apr 30, 2025 -23.94%
Jan 31, 2025 -137.23%
Oct 31, 2024 -122.21%
Jul 31, 2024 -111.90%
Apr 30, 2024 -105.24%
Jan 31, 2024 -11.54%
Oct 31, 2023 -12.86%
Jul 31, 2023 -15.76%
Apr 30, 2023 -17.98%
Jan 31, 2023 -19.14%
Oct 31, 2022 -15.13%
Jul 31, 2022 -64.18%
Apr 30, 2022 -68.78%
Jan 31, 2022 -65.03%
Oct 31, 2021 -60.21%
Jul 31, 2021 -21.23%
API Access

Rafael Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RFL&period=max&api_key=YOUR_API_KEY